PDY
- Product code
- PDY
- Device name
- Organophosphate Test System
- Device class
- Class 2
- 21 CFR
- 21 CFR 862.3652
- Medical specialty
- Clinical Toxicology
- Marketing pathway
- 510(K)
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
For the quantitation of specific organophosphate metabolites in human urine from individuals who have signs and symptoms consistent with cholinesterase poisoning. The data obtained by this device is intended to aid in the confirmation and investigation of organophosphate exposure.
Official FDA classification page: PDY
Classification and pathway per current FDA publications. Data from openFDA (CC0).